Sodium Thiosulfate Improves Hypertension in Rats with Adenine-Induced Chronic Kidney Disease

Hypertension is highly prevalent in chronic kidney disease (CKD). Hydrogen sulfide (H<sub>2</sub>S) is an endogenously produced gasotransmitter with vasodilator properties. We, hence, investigated whether oral administration of sodium thiosulfate (STS), a clinically applicable H<sub&g...

Full description

Bibliographic Details
Main Authors: Chien-Ning Hsu, Chih-Yao Hou, Guo-Ping Chang-Chien, Sufan Lin, Hung-Wei Yang, You-Lin Tain
Format: Article
Language:English
Published: MDPI AG 2022-01-01
Series:Antioxidants
Subjects:
Online Access:https://www.mdpi.com/2076-3921/11/1/147
_version_ 1797496174937112576
author Chien-Ning Hsu
Chih-Yao Hou
Guo-Ping Chang-Chien
Sufan Lin
Hung-Wei Yang
You-Lin Tain
author_facet Chien-Ning Hsu
Chih-Yao Hou
Guo-Ping Chang-Chien
Sufan Lin
Hung-Wei Yang
You-Lin Tain
author_sort Chien-Ning Hsu
collection DOAJ
description Hypertension is highly prevalent in chronic kidney disease (CKD). Hydrogen sulfide (H<sub>2</sub>S) is an endogenously produced gasotransmitter with vasodilator properties. We, hence, investigated whether oral administration of sodium thiosulfate (STS), a clinically applicable H<sub>2</sub>S-based therapy, can exert a protective effect against hypertension in an adenine-induced CKD rat model. Eight-week-old male Sprague–Dawley rats were fed with 0.5% adenine chow for 3 weeks to induce CKD. After 1 week, the rats were divided into two groups: one without and one with STS (2 g/kg body weight/day) in drinking water for 2 weeks. Treatment with STS lowered systolic and diastolic blood pressure by 7 and 9 mm Hg, respectively. Renal H<sub>2</sub>S-generating enzyme expression was inhibited by CKD, while STS therapy increased plasma levels of H<sub>2</sub>S and thiosulfate. Additionally, restoration of nitric oxide bioavailability and rebalance of the renin–angiotensin system may contribute to the protective effects of STS. Our data suggest that the oral administration of STS improves hypertension in an adenine-induced CKD model, which brings us closer to the clinical translation of H<sub>2</sub>S-targeting therapy in CKD-induced hypertension.
first_indexed 2024-03-10T01:59:55Z
format Article
id doaj.art-82a41ee4b920476f97457fbd02267086
institution Directory Open Access Journal
issn 2076-3921
language English
last_indexed 2024-03-10T01:59:55Z
publishDate 2022-01-01
publisher MDPI AG
record_format Article
series Antioxidants
spelling doaj.art-82a41ee4b920476f97457fbd022670862023-11-23T12:48:05ZengMDPI AGAntioxidants2076-39212022-01-0111114710.3390/antiox11010147Sodium Thiosulfate Improves Hypertension in Rats with Adenine-Induced Chronic Kidney DiseaseChien-Ning Hsu0Chih-Yao Hou1Guo-Ping Chang-Chien2Sufan Lin3Hung-Wei Yang4You-Lin Tain5Department of Pharmacy, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung 833, TaiwanDepartment of Seafood Science, National Kaohsiung University of Science and Technology, Kaohsiung 811, TaiwanCenter for Environmental Toxin and Emerging-Contaminant Research, Cheng Shiu University, Kaohsiung 833, TaiwanCenter for Environmental Toxin and Emerging-Contaminant Research, Cheng Shiu University, Kaohsiung 833, TaiwanInstitute of Medical Science and Technology, National Sun Yat-sen University, Kaohsiung 804, TaiwanDepartment of Pediatrics, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung 833, TaiwanHypertension is highly prevalent in chronic kidney disease (CKD). Hydrogen sulfide (H<sub>2</sub>S) is an endogenously produced gasotransmitter with vasodilator properties. We, hence, investigated whether oral administration of sodium thiosulfate (STS), a clinically applicable H<sub>2</sub>S-based therapy, can exert a protective effect against hypertension in an adenine-induced CKD rat model. Eight-week-old male Sprague–Dawley rats were fed with 0.5% adenine chow for 3 weeks to induce CKD. After 1 week, the rats were divided into two groups: one without and one with STS (2 g/kg body weight/day) in drinking water for 2 weeks. Treatment with STS lowered systolic and diastolic blood pressure by 7 and 9 mm Hg, respectively. Renal H<sub>2</sub>S-generating enzyme expression was inhibited by CKD, while STS therapy increased plasma levels of H<sub>2</sub>S and thiosulfate. Additionally, restoration of nitric oxide bioavailability and rebalance of the renin–angiotensin system may contribute to the protective effects of STS. Our data suggest that the oral administration of STS improves hypertension in an adenine-induced CKD model, which brings us closer to the clinical translation of H<sub>2</sub>S-targeting therapy in CKD-induced hypertension.https://www.mdpi.com/2076-3921/11/1/147symmetric dimethylargininechronic kidney diseasehydrogen sulfidehypertensionnitric oxiderenin–angiotensin system
spellingShingle Chien-Ning Hsu
Chih-Yao Hou
Guo-Ping Chang-Chien
Sufan Lin
Hung-Wei Yang
You-Lin Tain
Sodium Thiosulfate Improves Hypertension in Rats with Adenine-Induced Chronic Kidney Disease
Antioxidants
symmetric dimethylarginine
chronic kidney disease
hydrogen sulfide
hypertension
nitric oxide
renin–angiotensin system
title Sodium Thiosulfate Improves Hypertension in Rats with Adenine-Induced Chronic Kidney Disease
title_full Sodium Thiosulfate Improves Hypertension in Rats with Adenine-Induced Chronic Kidney Disease
title_fullStr Sodium Thiosulfate Improves Hypertension in Rats with Adenine-Induced Chronic Kidney Disease
title_full_unstemmed Sodium Thiosulfate Improves Hypertension in Rats with Adenine-Induced Chronic Kidney Disease
title_short Sodium Thiosulfate Improves Hypertension in Rats with Adenine-Induced Chronic Kidney Disease
title_sort sodium thiosulfate improves hypertension in rats with adenine induced chronic kidney disease
topic symmetric dimethylarginine
chronic kidney disease
hydrogen sulfide
hypertension
nitric oxide
renin–angiotensin system
url https://www.mdpi.com/2076-3921/11/1/147
work_keys_str_mv AT chienninghsu sodiumthiosulfateimproveshypertensioninratswithadenineinducedchronickidneydisease
AT chihyaohou sodiumthiosulfateimproveshypertensioninratswithadenineinducedchronickidneydisease
AT guopingchangchien sodiumthiosulfateimproveshypertensioninratswithadenineinducedchronickidneydisease
AT sufanlin sodiumthiosulfateimproveshypertensioninratswithadenineinducedchronickidneydisease
AT hungweiyang sodiumthiosulfateimproveshypertensioninratswithadenineinducedchronickidneydisease
AT youlintain sodiumthiosulfateimproveshypertensioninratswithadenineinducedchronickidneydisease